Emergence of Linezolid-Resistant <i>Staphylococcus aureus</i> after Prolonged Treatment of Cystic Fibrosis Patients in Cleveland, Ohio
Andrea Endimiani(University of Bern), Robert A. Bonomo(Louis Stokes Cleveland VA Medical Center), Michael D. Reed(Akron Children's Hospital), Michael W. Konstan(Case Western Reserve University), Kristine M. Hujer(Louis Stokes Cleveland VA Medical Center), Louis B. Rice(Brown University), Andrea M. Hujer(University School), Vincent Perreten(University of Bern), Michael R. Jacobs(University Hospitals of Cleveland), Saralee Bajaksouszian(University Hospitals Cleveland Medical Center), Elliott C. Dasenbrook(Cleveland Clinic), Susan D. Rudin(Louis Stokes Cleveland VA Medical Center), Martha Blackford(Boston Children's Hospital)
Cited by 102
Related Papers
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>
|New England Journal of Medicine|2015|1.6k
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
|Clinical Microbiology and Infection|2021|1k
Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- <i>CFTR</i> Mutation
|New England Journal of Medicine|2010|802